CELIA PRINCE: Open Payments
NPI 1215444062 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 6 payments from 5 companies in 2025. Trend: 2023 $236 · 2024 $254 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $176 |
| UCB, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $116 |
| Novartis Pharmaceuticals Corporation | 1 | $91 |
| Amgen Inc. | 1 | $31 |
Products named: TREMFYA, Bimzelx, SKYRIZI, COSENTYX, UPLIZNA.
Industry payments across TN — which companies pay providers there.
